乳腺癌临床试验招募信息（全球在招）

这里汇总了全球正在招募患者的 乳腺癌（国际通用名 breast cancer）新药临床试验，包含试验分期、招募状态、开展国家和研究团队联系方式，全部以中文呈现。数据实时来自全球最大的临床试验注册库 ClinicalTrials.gov。本页同时覆盖乳癌、三阴性乳腺癌、TNBC、HER2 乳腺癌等说法。

正在招募的乳腺癌新药试验

• Study of SHR-A1811 Combined With Pyrotinib and Bevacizumab in Advanced Breast Cancer With Brain Metastasis

  I 期 / II 期招募中中国NCT06718933

• Robustness Evaluation of Deep Inspiration Breath-Hold (DIBH) Plans in Internal Mammary Irradiation

  不适用招募中中国NCT07498855

• A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

  I 期 / II 期招募中美国Puerto RicoNCT07109726

• An In-situ Detection for MicroRNA

  不适用招募中中国NCT06529614

• ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

  III 期招募中美国Puerto RicoNCT06876714

• Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain

  II 期招募中美国NCT06848348

• The Development of MASLD Among Survivors of Breast or Colorectal Cancer

  不适用招募中SwitzerlandNCT07280143

• A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

  I 期 / II 期招募中美国日本NCT07488676

• Anlotinib-based Combination Therapy in Patients with Hormone Receptor-positive（HR+） Metastatic Breast Cancer(MBC) .

  不适用招募中中国NCT06734533

• Precision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNA

  I 期招募中LebanonNCT06307249

• Cancer Genetic Testing in Ethnic Populations

  不适用招募中美国NCT04475640

• Atezolizumab and Chemotherapy Treatment as T-cell Activators in Metastatic Triple Negative Breast Cancer Patients

  II 期招募中意大利NCT06690840